Vidyya Medical News Service
Volume 5 Issue 291 Published - 14:00 UTC 08:00 EST 18-Oct-2003 Next Update - 14:00 UTC 08:00 EST 19-Oct-2003
little clear gif used for spacer

FDA approves memantine (Namenda) for Alzheimer's disease
The Food and Drug Administration (FDA) today approved memantine(NAMENDA), for treatment of moderate to severe Alzheimerís Disease. This is the first drug approved for the treatment of patients with this severity of disease. Previous treatments for Alzheimerís Disease have been studied in less severely affected (mild to moderate) patients. Memantineís mechanism of action is different from that of the drugs currently available for treating this disease.  more

Prescribing information: Namenda (memantine HCl)
Namenda (memantine HCl) is contraindicated in patients with known hypersensitivity to memantine HCL or to any excipients used in the formulation. The most common adverse events reported with Namenda vs placebo (greater than or equal to 5% and greater than placebo) were dizziness, confusion, headache, and constipation. In patients with severe renal impairment the use of Namenda has not been systemically evaluated and is not recommended.  more


Information for patients: Questions and answers about Namenda
Namenda (memantine HCl) is the first medication approved in the United States to treat moderate to severe Alzheimer's disease. It works differently than the medications presently available on the market.  more

Study looks at how teens search for health information on the Internet
In a study of how teen-agers search the Internet for answers to health questions, University of Michigan researchers found that misspelled words, ambiguous search terms and an imprecise approach to scanning a Web site often prevented students from finding the information they sought. more

Heart attack patients don't maintain exercise program
Even patients recovering from heart attacks and other serious cardiovascular problems have trouble maintaining a regular exercise program, according to researchers at Case Western Reserve University's Frances Payne Bolton School of Nursing. The research findings were presented today at the annual meeting of the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) in Kansas City.  more

little clear gif used for a space